Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Cymabay Therapeutics (CBAY)

12.07 -0.23 (-1.87%)

04-24 16:00

Open:

12.46

Pre. Close:

12.3

High:

12.6836

Low:

11.8632

Volume:

562,802

Market Cap:

706M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

12.693 - 12.762

12.762 - 12.82

Low:

11.698 - 11.781

11.781 - 11.851

Close:

11.943 - 12.072

12.072 - 12.178

Technical analysis  (as of: 2018-04-24 4:23:11 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 15.51     One year: 17.52

Support:

Support1: 10.50    Support2: 8.74

Resistance:

Resistance1: 13.28    Resistance2: 15.00

Pivot:

12.51

Moving Averages:

MA(5): 12.82     MA(20): 12.34

MA(100): 11.56     MA(250): 8.53

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.07

%K %D:

%K(14,3): 46.74     %D(3): 54.62

RSI:

RSI(14): 44.91

52-Week:

High: 15.59  Low: 3.16  Change(%): 259.2

Average Vol(K):

3-Month: 131230  10-Days 202603

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CBAY has closed above bottom band by 36.7%. Bollinger Bands are 31.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-13T09:17:12-04:00
Biotechs, Whipsawed By Volatility, Still Remain Well-Positioned

2018-04-12T00:50:52-04:00
CymaBay Therapeutics Pushes Itself To The Next Stage Against Rare Liver Disease

2018-04-11T12:50:23-04:00
Midday Gainers / Losers (04/11/2018)

2018-04-11T09:21:26-04:00
Premarket Gainers as of 9:05 am (04/11/2018)

2018-04-11T09:08:00-04:00
CymaBay up 11% premarket on positive mid-stage seladelpar data

2018-03-20T12:01:06-04:00
Biotechs Approaching New Waters

2018-03-16T10:25:46-04:00
Key events next week - healthcare

2018-03-15T23:07:07-04:00
CymaBay Therapeutics' (CBAY) CEO Sujal Shah on Q4 2017 Results - Earnings Call Transcript

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

58.50

Shares Float (M)

58.12

% Held by Insiders

0.90

% Held by Institutions

60.90

Shares Short (K)

2466

Shares Short Prior Month (K)

2720

Stock Financials

EPS

-0.830

EPS Est. Current Year

-0.820

EPS Est. Next Year

-0.740

EPS Est. Next Quarter

-0.160

Forward EPS

-0.940

Book Value (p.s.)

9.170

PEG Ratio

Profit Margin

Operating Margin

-187.25

Return on Assets (ttm)

-44.6

Return on Equity (ttm)

-62.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.370

Qtrly Earnings Growth

Operating Cash Flow (M)

-19.63

Levered Free Cash Flow (M)

-5.22

atoplab.com

Valuation

P/E

-14.54

P/E Growth Ratio

-0.02

P/BV

1.32

P/S

2434810368.00

P/CF

-35.97

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.